Organisations That Support SMEs to Generate Evidence for NHS Adoption
Sector insightsA visual guide to the organisations that support early- and later-stage SMEs to generate the evidence required for NHS adoption.
Overview
This infographic outlines the organisations involved in supporting SMEs to generate the evidence required for NHS adoption across both early and later development stages. Early-stage companies typically focus on value proposition, regulatory status and prototype feasibility, supported by groups such as the NIHR Research Design Service, Biomedical Research Centres and Patient Safety Translational Research Centres. Later-stage SMEs require evidence on safety, efficacy, usability and health economics in relevant NHS care settings. Support at this stage includes MHRA, NICE, the Health Research Authority, NIHR Clinical Research Networks, Medtech and Diagnostics Co-operatives, Academic Health Science Networks and Clinical Research Facilities. Navigation support is also provided by groups including MedCity, the NIHR Office for Clinical Research Infrastructure (NOCRI) and the Northern Health Science Alliance.
Key takeaways
- Support varies by development stageEarly-stage SMEs receive guidance on value proposition, regulatory pathways and feasibility, while later-stage SMEs gain support for generating evidence on safety, efficacy, usability and health economics.
- A broad ecosystem of evidence partnersSupport comes from NIHR centres and networks, MHRA, NICE, HRA, AHSNs, clinical facilities, patient advocacy groups and NHS care settings, providing expertise from research design through to real-world evaluation.
- Dedicated navigation for SMEsMedCity, NOCRI and the Northern Health Science Alliance offer navigation support, helping SMEs connect with investigators, NHS partners and infrastructure during evidence generation.
Organisations That Support SMEs to Generate Evidence for NHS Adoption
Sector insightsA visual guide to the organisations that support early- and later-stage SMEs to generate the evidence required for NHS adoption.
Overview
This infographic outlines the organisations involved in supporting SMEs to generate the evidence required for NHS adoption across both early and later development stages. Early-stage companies typically focus on value proposition, regulatory status and prototype feasibility, supported by groups such as the NIHR Research Design Service, Biomedical Research Centres and Patient Safety Translational Research Centres. Later-stage SMEs require evidence on safety, efficacy, usability and health economics in relevant NHS care settings. Support at this stage includes MHRA, NICE, the Health Research Authority, NIHR Clinical Research Networks, Medtech and Diagnostics Co-operatives, Academic Health Science Networks and Clinical Research Facilities. Navigation support is also provided by groups including MedCity, the NIHR Office for Clinical Research Infrastructure (NOCRI) and the Northern Health Science Alliance.
Key takeaways
- Support varies by development stageEarly-stage SMEs receive guidance on value proposition, regulatory pathways and feasibility, while later-stage SMEs gain support for generating evidence on safety, efficacy, usability and health economics.
- A broad ecosystem of evidence partnersSupport comes from NIHR centres and networks, MHRA, NICE, HRA, AHSNs, clinical facilities, patient advocacy groups and NHS care settings, providing expertise from research design through to real-world evaluation.
- Dedicated navigation for SMEsMedCity, NOCRI and the Northern Health Science Alliance offer navigation support, helping SMEs connect with investigators, NHS partners and infrastructure during evidence generation.
